HOME


sh-3ll 1.0
DIR:/home/medisavehealth/mail/new/
Upload File :
Current File : //home/medisavehealth/mail/new/1771385115.M825870P3774931.usvip2.noc404.com,S=50695,W=51576
Return-Path: <>
Delivered-To: medisavehealth@usvip2.noc404.com
Received: from usvip2.noc404.com
	by usvip2.noc404.com with LMTP
	id sKkpMRsxlWnTmTkAivPwkw
	(envelope-from <>)
	for <medisavehealth@usvip2.noc404.com>; Wed, 18 Feb 2026 03:25:15 +0000
Return-path: <>
Envelope-to: info@medisavehealthcarebd.com
Delivery-date: Wed, 18 Feb 2026 03:25:15 +0000
Received: from mail-northcentralusazhn15012040.outbound.protection.outlook.com ([52.102.146.40]:10657 helo=CH5PR02CU005.outbound.protection.outlook.com)
	by usvip2.noc404.com with esmtps  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.98.1)
	id 1vsYBc-0000000Ft0G-0yTh
	for info@medisavehealthcarebd.com;
	Wed, 18 Feb 2026 03:25:15 +0000
ARC-Seal: i=1; a=rsa-sha256; s=arcselector10001; d=microsoft.com; cv=none;
 b=xqi9WH6MMv2BXSNNObLVic+V5Fisl/0KaQek2c2EQcuJqASW8YIh2dZPKwkWMe/26Y29XHCpcUE8GqbgseIfa4t94qMx+n8FKWECA+fOYpsfgfOY+y9UX/m557OHnoou0oDoI3E+Yiq/ywunWn9zRWWnPIoqDwiEwRyCe1i7pT0gBVsiBWlBo0jEv5mTa7bBKgCPyKNyVMK/9ANgEHTA/iZ3/6m26f0Q3rBsSrNyZI+s8acoGtid20lwtFh7qQY8lBUopSkkr9V93VSuBsj9GHGGWe3wCqCZARUunj8KkmKI9AiO3cDejX21l8TN9EU4rInkkvllS4AHSXyUe2jlFA==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com;
 s=arcselector10001;
 h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1;
 bh=ZminaRZRyXqr8/v0vcKq9TKQ3yYfj5G9lSZaOIrpFyU=;
 b=ranGwph7W7ttzmz7ZNIV6NDM9suB4MMs7jxGMpH1ifKuLq/JLPDndBF5mA+KNTTkcq1TMPF4WIe4hx+Dcpdp79dgYbV6d+STkt1PLSIWHzDyMX8+6SS9g2TIEH4LFAXZY6Y51BefTeQIylAIwVBRJjSb584mVZku033xBvk8RrXuRwOD3AMNuL6q+15+R9WcjUhFXyV2zwCEYV/OvSFWy7vf4klRz98jRM8t97COLEgbUXlAOH1xoxxrxSKTPwHlFQ0ybZxP1CjWAs0FlJsI5Dr9Y9+u9ZIYpQe0dCkz2uYMX62xJ5IreEVlWDECDjBLEXsnLLyJ7UOp5Y0XgdPSDg==
ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=none; dmarc=pass
 action=none header.from=deloitte.onmicrosoft.com; dkim=pass
 header.d=deloitte.onmicrosoft.com; arc=none
MIME-Version: 1.0
From: <postmaster@deloitte.onmicrosoft.com>
To: <info@medisavehealthcarebd.com>
Date: Wed, 18 Feb 2026 03:24:16 +0000
Content-Type: multipart/report; report-type=delivery-status;
	boundary="43b1ee51-0de4-455b-bef9-bb8a1447359a"
X-MS-Exchange-Message-Is-Ndr:
Content-Language: en-US
Message-ID:
 <4a300d6a-21e5-43e2-af31-837300948844@AM0PR85MB0274.NAMPRD85.PROD.OUTLOOK.COM>
In-Reply-To:
 <177138504257.270981.1055917534760383877@medisavehealthcarebd.com>
References: <177138504257.270981.1055917534760383877@medisavehealthcarebd.com>
Subject: Undeliverable: Current Invoice
 Notification_#37e8e08c-56d0-f7ca-7e24-726df5acea03
Auto-Submitted: auto-replied
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: AM0PR85MB0274:EE_
X-MS-Exchange-SenderADCheck: 1
X-MS-Exchange-AntiSpam-Relay: 0
X-Microsoft-Antispam:
	BCL:0;ARA:13230040|50650200027|4022899009|6049299003|366016|1930700014|376014|1800799024|19033499003|8096899003|4053099003|3613699012|13003099007|32400700002;
X-Microsoft-Antispam-Message-Info:
	=?us-ascii?Q?LmQngunMxLeaup74USCq/8CaNxO/q0MytnsvTEiTVerr4X4wPPNHlYpcCmbR?=
 =?us-ascii?Q?2JIjMSx4zHfAHvkaNM7aXLmz98dS4b6lYzOL8i0zp+gK8KygObHOOpaSQXYY?=
 =?us-ascii?Q?Xxe4wWkjEM6IuPTDjhXDkM9R2wRpLHZv65le+ESQfAabwNC250OPRU+4oRLA?=
 =?us-ascii?Q?+zbF02elnVwseMaxj2WStEULfnpnxKqjriboWe22NDN8yPKYXarK8qVbyWxq?=
 =?us-ascii?Q?YrnDKH/iQy4jEpeZ7WR6B5zGHJn7wZOcBsm2AksZPzr5lFiVMwvbrR5O8X7y?=
 =?us-ascii?Q?2N0w4W0+Zq7D+webX5Tks9GpUMivd17FyXZKlpdvcoi/fojvJe2w1DQx5pK0?=
 =?us-ascii?Q?NLVdLyk5OKi4D8YX2UVdLhk2PIAzu3hXcqWkluQ5VKoMh8/OOj55712+SsdG?=
 =?us-ascii?Q?jmHp+RvHKJOI09gFXSQn+0k0n5AuZzWQOvJsuG0YVydDIaZAgoZfQAmox+2t?=
 =?us-ascii?Q?DAR5/adWkfbpi557nW8C77ehKxDTQF6YTmjSsWQ4rTI71L8tviB//bdI7Azk?=
 =?us-ascii?Q?Snlsx+W9GF0sRy6160odks5CDx38Wh+lpEjE12Hr27AMWRjPPcSu0+z/YNSd?=
 =?us-ascii?Q?HasNZPr25jdBQRiijMlM++u3bx/Sd/IFgsEsj3G+fig4vCN55aDANgLLSg/S?=
 =?us-ascii?Q?D8xSslonMfUJVG5fzfe8MDxGGTrgkODN4QSptQuYiUQuFm7vqLGq67tWckvd?=
 =?us-ascii?Q?8GZTwgB8R30cZL1b8xGdh7w9PnF3REaSh9VN9cwp+cnvw6iXc8Np6DUfx278?=
 =?us-ascii?Q?W9Izg4IKgILkOZAiUpbApOehT0lCvot+u42JG73ys69sk0Gyf+UGltSqGVsD?=
 =?us-ascii?Q?fN1AEG6l991rSDDj9s1qZL6kIksFBS/t1BUw4zuNLODprF6hUcrLT/PkYebd?=
 =?us-ascii?Q?VAzFW/ZQXVNvM8IYNnWEGu6PNjiVqj+ExaqK7vR6aNrEvuI9ubMvWc4Xbxwq?=
 =?us-ascii?Q?jOdekNoSMdBwS37P4OfuZ8ov84aku2/mlcwCmFIb7X//bOdCw0plzzwJwNz9?=
 =?us-ascii?Q?c5B/NxRiRnsNveqYptjGkeGWFTfTuhLiYcd1P4JTTrOr1eN7vHhCMtLoN2vs?=
 =?us-ascii?Q?mXJapvLqlxCSCNX5yBMwD6YUWgDjCI+FczdvCjBeYXr+KUE6XDRVGte2WaWd?=
 =?us-ascii?Q?6hmT0x9Gu1yqP+mbq07x0HdvxHTf35eymjYOtfoUqe+iqWAW3rSI4QeB0UCW?=
 =?us-ascii?Q?18+E8ZxApxreIG36WxMac7st/VzzmyqHMmqGh+yU0FKxD6fl3be6NaQ+2hWg?=
 =?us-ascii?Q?hlWr0l3n1mr1ox1XsmstVnn69sNumG0v3UJXUaqwFF7O/Env8IJ2gkmXFI8Z?=
 =?us-ascii?Q?4rUD9Yn90lPeSUUvXtAf2IOF+O+eLZKGhdD/sgFtt0llcwGV3oN702JQEGDD?=
 =?us-ascii?Q?AS0jzje7BNWgW2m2dnrl3kbJDtWwXhZ8t0eAQeVbt1Uasq98SsJNz+1vYjHF?=
 =?us-ascii?Q?8ofUHYFLurqOOnufWzDNOnz+cDXa6rySOFaF2oxKx8Tos4xNJJsOE0YSePuX?=
 =?us-ascii?Q?BAu0UrTSeKj8hgxbkyDNcbfdiVfpVcRO8hyUTW1EJC1HDDUOcEexhRTNJA8/?=
 =?us-ascii?Q?HCafz9cObKFMFyTCEh3gR6b3PFDo5NHDciepRnT2UFcPhlWiM3uVnGilwWko?=
 =?us-ascii?Q?XgD/LmMkFAs3JvJYvLyc8vC2bE5YGVdRLE+/Xt6kda4A0xhyGsFjoYRHzhXg?=
 =?us-ascii?Q?a/QnE2Zylxwuz/epyi5CejbcaNZsrL+6PCnchjmCUgLlX93MgBNAet14NYiC?=
 =?us-ascii?Q?EQwIdfltvA=3D=3D?=
X-Forefront-Antispam-Report:
	CIP:255.255.255.255;CTRY:;LANG:en;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:;PTR:;CAT:NONE;SFS:(13230040)(50650200027)(4022899009)(6049299003)(366016)(1930700014)(376014)(1800799024)(19033499003)(8096899003)(4053099003)(3613699012)(13003099007)(32400700002);DIR:OUT;SFP:1501;
X-MS-Exchange-AntiSpam-MessageData-ChunkCount: 1
X-MS-Exchange-AntiSpam-MessageData-0:
	38c9vXVpyJjdqXZWZsxolhCVWQMyPuhoMDiZo0xvMesHo2QqSnND+MC8+196vE8wEwbInZfb1bebtNtDBS7QfMxwJrCwL4AvOfkcA6JKiZ3eS9SAYF536eY5Q0kw5Le5heNS+gHtv1oSzUYq7fY+zRERwQSKYlJHNeJxp+hEHZVIUETR3EFJf38Jbr4puPUuM2FJytitIIb8NbKrU0768KhjKgPbmLefURrClAik2zYd8mYIGGwgwfIuGPfJAiQG+YIiyQURCYPl+T9sNOyw++FGJbsIpm9+/cTayAFRoeomF2I5f07XV6g/98Vsjf/m/vFc+cB9w3Vmcvz27K3h+w==
X-OriginatorOrg: deloitte.onmicrosoft.com
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 18 Feb 2026 03:24:16.3171
 (UTC)
X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted
X-MS-Exchange-CrossTenant-AuthSource: AM0PR85MB0274.NAMPRD85.PROD.OUTLOOK.COM
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-Network-Message-Id:
	3e76c8d1-2085-4b9e-d23b-08de6e9d3221
X-MS-Exchange-Transport-CrossTenantHeadersStamped: AM0PR85MB0274
X-Spam-Status: No, score=-0.1
X-Spam-Score: 0
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "usvip2.noc404.com",
 has NOT identified this incoming email as spam.  The original
 message has been attached to this so you can view it or label
 similar future email.  If you have any questions, see
 root\@localhost for details.
 Content preview:  Delivery has failed to these recipients or groups: lfissering@deloitte.com<mailto:lfissering@deloitte.com>
    Your message couldn't be delivered to the recipient because you don't have
    permission to send to it. 
 Content analysis details:   (-0.1 points, 5.0 required)
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  0.0 URIBL_BLOCKED          ADMINISTRATOR NOTICE: The query to URIBL was blocked.
                             See
                             http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
                              for more information.
                             [URI: medisavehealthcarebd.com]
                             [URI: office365.com]
  0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to
                              Validity was blocked.  See
                             https://knowledge.validity.com/hc/en-us/articles/20961730681243
                              for more information.
                             [52.102.146.40 listed in bl.score.senderscore.com]
  0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE: The
                             query to Validity was blocked.  See
                             https://knowledge.validity.com/hc/en-us/articles/20961730681243
                              for more information.
                          [52.102.146.40 listed in sa-trusted.bondedsender.org]
  0.0 RCVD_IN_VALIDITY_SAFE_BLOCKED RBL: ADMINISTRATOR NOTICE: The query to
                              Validity was blocked.  See
                             https://knowledge.validity.com/hc/en-us/articles/20961730681243
                              for more information.
                             [52.102.146.40 listed in sa-accredit.habeas.com]
  0.0 T_SPF_HELO_TEMPERROR   SPF: test of HELO record failed (temperror)
 -0.1 ARC_VALID              Message has a valid ARC signature
  0.0 ARC_SIGNED             Message has a ARC signature
  0.0 KAM_DMARC_STATUS       Test Rule for DKIM or SPF Failure with Strict
                             Alignment
  0.0 HTML_MESSAGE           BODY: HTML included in message
X-Spam-Flag: NO

--43b1ee51-0de4-455b-bef9-bb8a1447359a
Content-Type: multipart/alternative; differences=Content-Type;
	boundary="68fda064-7efe-4ad3-8bbd-a06ea6e28640"

--68fda064-7efe-4ad3-8bbd-a06ea6e28640
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

Delivery has failed to these recipients or groups:

lfissering@deloitte.com<mailto:lfissering@deloitte.com>
Your message couldn't be delivered to the recipient because you don't have =
permission to send to it.

Ask the recipient's email admin to add you to the accept list for the recip=
ient.

For more information, see DSN 5.7.129 Errors in Exchange Online and Office =
365<https://go.microsoft.com/fwlink/?LinkId=3D389365>.









Diagnostic information for administrators:

Generating server: AM0PR85MB0274.NAMPRD85.PROD.OUTLOOK.COM

lfissering@deloitte.com
Remote server returned '550 5.7.129 RESOLVER.RST.RestrictedToRecipientsPerm=
ission; not authorized to send to recipient because the sender isn't on the=
 recipient's list of senders to accept mail from'

Original message headers:

Received: from DM8PR85CA0006.NAMPRD85.PROD.OUTLOOK.COM (2603:10b6:5:2d8::33=
)
 by AM0PR85MB0274.NAMPRD85.PROD.OUTLOOK.COM (2603:10a6:20b:20d::8) with
 Microsoft SMTP Server (version=3DTLS1_2,
 cipher=3DTLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9564.22; Wed, 18 =
Feb
 2026 03:24:14 +0000
Received: from DS1PEPF00017090.namprd03.prod.outlook.com
 (2a01:111:f403:f904::b) by DM8PR85CA0006.outlook.office365.com
 (2603:10b6:5:2d8::33) with Microsoft SMTP Server (version=3DTLS1_3,
 cipher=3DTLS_AES_256_GCM_SHA384) id 15.20.9564.22 via Frontend Transport; =
Wed,
 18 Feb 2026 03:24:12 +0000
Authentication-Results: spf=3Dpass (sender IP is 192.200.120.82)
 smtp.mailfrom=3Dmedisavehealthcarebd.com; dkim=3Dnone (message not signed)
 header.d=3Dnone;dmarc=3Dbestguesspass action=3Dnone
 header.from=3Dmedisavehealthcarebd.com;
Received-SPF: Pass (protection.outlook.com: domain of medisavehealthcarebd.=
com
 designates 192.200.120.82 as permitted sender)
 receiver=3Dprotection.outlook.com; client-ip=3D192.200.120.82;
 helo=3Dusvip2.noc404.com; pr=3DC
Received: from esa.deloitte.iphmx.com (68.232.130.230) by
 DS1PEPF00017090.mail.protection.outlook.com (10.167.17.132) with Microsoft
 SMTP Server (version=3DTLS1_2, cipher=3DTLS_ECDHE_RSA_WITH_AES_256_GCM_SHA=
384) id
 15.20.9632.12 via Frontend Transport; Wed, 18 Feb 2026 03:24:11 +0000
X-CSE-ConnectionGUID: kxaWD6/5SnCFDHmYfD/mvQ=3D=3D
X-CSE-MsgGUID: xFhCU4qkQ3q/x2v3iP0QfA=3D=3D
Authentication-Results-Original: esa.deloitte.iphmx.com; dkim=3Dnone (messa=
ge
 not signed) header.i=3Dnone; spf=3DPass
 smtp.mailfrom=3Dinfo@medisavehealthcarebd.com
Received-SPF: Pass (esa.deloitte.iphmx.com: domain of
  info@medisavehealthcarebd.com designates 192.200.120.82 as
  permitted sender) identity=3Dmailfrom;
  client-ip=3D192.200.120.82; receiver=3Desa.deloitte.iphmx.com;
  envelope-from=3D"info@medisavehealthcarebd.com";
  x-sender=3D"info@medisavehealthcarebd.com";
  x-conformance=3Dspf_only; x-record-type=3D"v=3Dspf1";
  x-record-text=3D"v=3Dspf1 ip4:192.200.120.82 +a +mx
  +ip4:52.129.44.82 ~all"
X-Ironport-Dmarc-Check-Result: validskip
IronPort-SDR: 699530d8_DmSTmo+KRBFoit12pKHlskJLddgd5sGbsNxNGrDw4sE4zk9
 zzCb71hO+zlzZh8qVkTiH1CusueHY3jIFIj70uA=3D=3D
X-Deloitte-MX-Route: IncomingMail
X-External-Sender: True
X-SDR-Check: True
X-ThreatScanner-Verdict: Negative
X-IPAS-Result: =3D?us-ascii?q?A0CODgBLMJVp/1J4yMBagQmBUIJBBxMBIUkCgRIHUZFfh=
?=3D
 =3D?us-ascii?q?GygBQ8IDwEBAQEBAQEBAQkuFg0EAQGSKAIlATcGDgECBAEBAQEDAgMBAQEB=
A?=3D
 =3D?us-ascii?q?QEBAQEBAQsBAQEEAQEBAgEBAgQFAYENE4YgLw2CPR6ECQ8XHQgCJwkOTAdk=
B?=3D
 =3D?us-ascii?q?AEhgmGCIFMDBAEMn1kBgSw/AigBQAEMgQuJFXiBIQgLgQGEfNssBhiBNYhJ=
C?=3D
 =3D?us-ascii?q?wGBVIQcAwGBIoNYJxt9gRB6TYYXBBiBJAEBbYMnglAEK4MFgRKIeYlYgWYD=
W?=3D
 =3D?us-ascii?q?SwBPhcTFwsHBT6BKAN7C24yHVxHPhczWBsHBTuFOYF/DgGGTQEBAYETgSJ4=
b?=3D
 =3D?us-ascii?q?oEfWTQDC209BBIhFBsvj0NBgW91DBMQDQ6BFysVPS2BDD6POYJBKJFHD6Fq=
h?=3D
 =3D?us-ascii?q?CY0CYNDiB6WB4QEjROZVC6HbZBrjgmbBzGBRTkmgS4OHXAVgVmBSU8DGQ+N=
d?=3D
 =3D?us-ascii?q?gGEKr0jQTUSKgIHCwEBAwmSHQGBSQEB?=3D
IronPort-PHdr: A9a23:G0zfpBJL1/MBnj3NZdmcuLxiWUAX0o4c3iYr45Yqw4hDbr6kt8y7e
 hCEubM11BSTB9yGt7ptsKn/jePJYSQ4+5GPsXQPItRndiQuroE7uTJlK+O+TXPBEfjxciYhF
 95DXlI2t1uyMExSBdqsLwaK+i764jEdAAjwOhRoLerpBIHSk9631+ev8JHPfglEnjWwbL19I
 RmssQndqsYajZV8JqosyhbErWZDdvhLy29vOV+ckBHw69uq8pV+6SpQofUh98BBUaX+Yas1S
 KFTASolPW4o+sDlrAHPQwSX6HQTS2kbjBVGDRXd4B71Qpn+vC36tvFg2CaBJs35Uao0WTW54
 Kh1ThLjlToKOCQ48GHTjcxwkb5brRe8rBFx34LYfIeYP+d4c6jAf90VWHBBU95NWCNODI2yb
 5UBAfcCM+hXrYfzvVgBoACkBQm1Hu7i0CNEimPo0aA8zu8vERvG3AslH98WrHnUstP1NKYPX
 +Co1KnI1TLDb+lK2Tzg74XIcxYhof+LXb9rdMre11QgFwLejlqKt4zqITOV2foXvGif8+pgV
 f6ghHQ9qw5vuTeg290ghZXOhoIQ013J8zhyz4kpK9OiUkF7fcKkH4VKtyGcL4Z6X80vTW9ot
 Sg01rELpJG1cDUUxZk62hLSZeCLfouU7x/9VeucIip0iG9ldr6jmxq/8lSsx+PgW8So31hHr
 y5In9/RvX4Ozxze8tWLR/9j8ku7xzqDyxzf5vtZLUwqiabXMZ0szqAompcXrUjPBDP6lF/og
 KKZbEkp9Oql5uL6abv8vJCcLZV7igTmP6QuhMO/BeM4PxATX2iA5+S81aXj8VPjTLVMif05j
 qbUvIzVKMgBuqG5BApV3p4i6xa5ETimzMwVkWQDIV5bYh6LkZTlN03ULPzlE/uzn06gnTR1y
 /zeO73uGJTNLnzNkLf7erZ97lZRyAs1zdBR4JJZEbQBL+zuVU/wr9zXFAE5PBK0w+n5Etp90
 p8eWWKTDaCDKqPdr0SH6f81L+aQY48VvS7xK+I56P72kX85hVgdcLGt3ZsZaXC4Be9mLFuDY
 XrthNcBHnwHsRcgQ+zuj12CUCJTZ2qsUK4m+j47D4emAZ/FRo+2mLOBxju0HoVKZmBaDVCBC
 Wrke52LW/gSbyKcIdVvnyQKWra8U4Mhzw+htBH5xbR9NufU5zYYtYzi1Nht+eHfjxcy9TtoA
 MmSz22AQHt4kX8PRz8zxKxwvE99ylaG0aVgm/JWGtJc6e1VXAomM5DQ1/F1C9XoVQLbYtiEU
 E6oTMy+Dz8+Vt4x2McOY0hlFtu4kh3NwjekD6cOl7yTCpw76qLc0Gb1J8Z603vIzLAvgUEpT
 JgHCGu9m6Qq8gHSA5LOwVifjLugbq8G3STA3GKOwWuVtV9VUAN5VbnFVnkFa0Ha69/+4xD/S
 aSzA+EnLhdZ0pzFba5HZtzyhEtLRPrqPMjeaGurlm28Qx2Pw/SRapH3cX4WxiTXBR8JlgkS+
 SOCOwklHSq7omTRQWA2GV/rZELw7eQ4o3S+AFNhxlzSZBMw27DmxxgOmPa8Rvof06hRvS4gr
 ylzTku7xM/cENGapgBsVKBRbdIm6UlK1W/QsxB9NZW6IqpuwFUZdldKuVjz3TV6A4lNi50qs
 G8y11g1bqeV3FJafi2V3Z35PqHXIWDo8RqjLaXR3xbD1s2L8LwE8vUypgLuuQioEh8m/XR8y
 NRP0n2Tq8mSAAcWVpPtTktx/B9/6a2Pa3Rl7N2F2Xc/Da7htjHDwMkkHuojxT6sctNYMb+YG
 Un5FMhJKdKpLbkDhV6oVQ8cJOdI6OZgPsWocNOD1aKqJ+9+kTKrhGBb4It0yE+G+2x3Teuej
 MVN+O2RwgbSD2S0t1ymqM2iweisBBkfBWP5xSXgA49NeqA0fJ4LDHfoKMqylZ1yhJ/oDnhf8
 lPrR1YLw9SgdhfaaVvhlRZR2kIarT3vmSaxwzFu1TB8qK2Z0X+G2PzsISIOIXUDX2x+lRHpK
 ImwgcodWR2paQYuvB6o6UfhzrZWpKl2K3XTSk5SciL6aWplV8Ncr5K6atVUoNMlqiwRXOm4Z
 lGGVrO7ogMa1jOlFGxblng3cDSju5OxmBIf6irVLXB9q1LcdM1x3h7B6dzRTPpN3jEPXiRyh
 X/cAV30M9Sy/NqSnovOqajnBjjnDMULN3CxlcXQ7mOy/ggISVWnkuq2m8H7HARyyiL929RwF
 G3JoBv6foj3xvG/OONjcFNvAQyZiYIyEYV/n40swZAIjCFL3NPPpSJByD2rd4UBiurkYXEAR
 CAG2YvY+wGj1EBnKXOV24+/V22dx9snbN6/MQZ0kmow6d5HDKCM4flKhyxw9xC5qwzWSf1wk
 jYGwOUj6HMTh/0JswM3wy+RRLsVGAMLWE6k3wTN9N24oKhNMSyud7a3/E9zkdG6Ba+PogxVX
 Gr5cZ44ECV8qM54NRiftR+7opGhc97WY9UJsxSSmBqVlPBbH5U3kutZzToiI2/2umcpjvIql
 RE7l4/vp5CJci8+mcDxSg4dLDD+YNkfvy3gnboL1NjDxJihR91gAmlZBcqyC6jwSHRL76yhZ
 1zGUzR06XKLfNiXVUye8Bs08iiJSsr6cS3LYilDhcNrQB3XTKSwqAUZUDQhl4A0Fg2jwNDhe
 05j6zodoFX/r0kVot8=3D
IronPort-Data: A9a23:quuHKq2KOSryp7QHSPbD5SF7kn2cJEfYwER7XKvMYLTBsI5bp2RUn
 zQcCjzUPP6CYGOmc950bYSxo0IPvZ6DnYViQQNtqSg9HnlHgPSeCIXCJC8cHc8zwu4v7q5Dx
 59DAjUVBJlsFhcwgD/zYuC5xZVb/fjRGeKgYAL8EnkvA1ciE2F51U4Ld9cR2uZAmcK+Dx6Gp
 eT8qsjePE7N8zNvOycf5rnrRClH5ZwegxtG+AZnDRx3lAWGzSdNVstAffvZw0bQG+G4IMbrH
 44v85nkpgs1zz91Yvu5n7DydFE9Q7K6FWCmlnpMVqG+tQNJryo037xTHKJ0hZB/0mjhc3hZk
 b2hhLToIesbFvSkdNc1CXG0JxpD0Zhuo9crF5QeXfu7lCUqe1O0qxln4dpf0Ycwoo6bCkkWn
 RAUxaxkgh2r34qLLLyHpuZEhdQqE+W1e94kvFpO4RHcPPgKBpXdevCfjTNY9G9YasFmAO3AZ
 tJDLzxoZ0iYP1tEPVJ/5JAWxbbywCOnK3sB8grT9fBfD2v7lGSd1JDsNtTSUtmHScROl1iVp
 m/P+3j5CRgAOdaTjzGC9xpAg8eUxXykA9NNROfQGvhCkHOT7VFPER4vDkL8saOn0U+GA+tRA
 hlBksYphfNvrRX1F4OVsweDiHqKvwUHVsBRFeIS5AyJzavI/wvfDW8BJgOtc/Q7r9E3XWZs0
 FiCw4u1QzdotdV5VE5x6J+XvTqNFXZScFQETgEobQ407fWkpZ8K20enoslYLEKjsjHi9djNL
 92isTMghq1Jy8gM3PnjoRbMhDfESnn1ouwdu1i/soGNt1IRiGuZi2qAswizARFod9/xc7V5l
 CJY8/VyFchXZXxN/QTUKAn3IF1W2xp1GGaB2AcxRsNJG8WF9Hm5fIRU6SpzPllkKN1MeDniJ
 ifuhO6QjbcNVEaXgVhfONPgUJR0kPK/T7wIlJn8N7JzX3S4TyfflAkGWKJa9zqFfJEEyP9gZ
 cWoYoy3AGwECK9q6jOzSq1PmfUo3y0yjyebD5zy0x3tg/LUaW+3WIU1FgKETtk4y6eY/yTT0
 dJUbPWRxztlDebRXyjw8KwoF24sE0QVP57NhvZsRraxGTY+QGAFIN3N8IwlYL1gzvh0lP+X3
 3STWX146VvYhF/fIwC4dElMMbfdcpJtnEIJOSUDA1ai+0IkUNyB/ZUgVZgTeJ85/tdC1t9xd
 eEOIO+bM8RMSxPG2R4RaMTlkddcax+E1BOCFAj0RBMdbpJfVwjy1du8RTTW9Q4KEiaTnukvk
 Y2Kjw/0b8IKeFV/MZzwdvmq8WKUgVEcv+BDB23zPdhZfRTXwrhAciDeoKc+HJARFE/l2DCf6
 gexBCUYr8nrp6se0oHApYKAnreTP9pOJGhoNEiF0u/uLgjfxHSp/qFYWuXRfTz9anL9yJ//W
 cprlcPDIN81t3cUlbFjEoRb77M0vPrugL548j5KPlv2a3aTN7cxBUXegOdusPVWy657qDmGf
 BuF2uNnNIWjPOLnF18sJzQZUNmT6MFMihvvtM4LHEHc2hZ23aGmVBxSNiaciSYGI7pSNpgk8
 Ngbu8UXylKejxpyPvasnAdVp3qGEUIDWpUBtp0fPojZtSQwxn5CY63sKCvH5aiSWo8dLm1xH
 CKf35TDjO5610P9UX4LBFnW/O9nnZ9Vkgt7/FwDAFWom9T+mf482iNKwwk3Vgh4yhZm0fp5C
 lN0NkZwG7qCzw1oiOdHQWqoPQNLXz+dxWDc1HoLkzf/Y3Szd2mQMlA4B/mBzHoZ/01YYDJf2
 rOSk0ThcDTyefDOzjkAYlFkp9PjXO5O2FX7wu7/JPu8Hr4+fTbBqY2tbzBRqxLYXOUAtHeer
 uxupOtNean3MBALmJICCq6Y6K8xTS6VL2kTUNBj+6I0RVvnQg+Q4gTXCU6NeZJqHcfooGuYE
 M1lI/xdWyuujBiuqi8pPo9SArtWssNw2v88VOLFGWo0vYGbjAJVi7PL1y2nhGYUU9Rkysk8D
 YXKdgO9KG+bhFoKumrJsftBa0OyXucHbT3a3OywzuI7KLwYvM5sc3AC8L+FukyIAVE24zOVo
 wLxSKvExMNyyYlXvtXNE4cSIy6WON/MROCz3wTriOt3bPTLLcvqnCEEmGnNZgh5E+MYZIVqq
 O6rrtXy4nLggJ83dGLow7+6CKhD4JSJbtp9a87YAiFTonqfZZXK/RAGxmGfLK5JmvN74u2MZ
 VOxSOm0RO4vd+Zt/l9nQAkALE9FEIXyVLnqmg2lpffVChQ97x3OHOn6yVDXN1NkZg06ELygL
 DTrusSexMFS96VNIx4mO8tIIbFFJH3bZK93UOGp6Be5CDGzj0Kgq4nSs0MqyQv2B0muFOf45
 pP4RSbCSimihZGQzP9lntxzmjY1EEdChfIBexNB2txu1BG/Im00DcUcFpQkU5oPoDT5+LDlb
 jScbk0OIH3ZWBJaey7d+/XmZB+UXcYVC+f6Jxso3kKaUDi3D4W+G4lc9j9sznN1Wzn7xtGcN
 tAV/0PvMiiLwp1GQfgZ4tq5i7xFwsz2620p+0enteDPGDcbXKs30UJ+EDp3VSDoF9/HkGPJL
 zMXQUFGWESKdl7jI/1/enJ6GAArgx239m8GNRyw+df4v5mX6MZiy/elYuH67eAlXfQwfbULQ
 Sv6enuJ72WowUcsgKoOue8yoKpKGPmOT9mbLqjieFUopJuOyF8bZuEMoSlea/sZ2l97M0jcn
 TyS8XQBFBy7CERO6oa3lyQN2bxMC0wpMR+YqTXBgwL4rEEF8eX4ejyB7h7KFpXrmq2y42RaW
 GgzaWiSkX23tRzlhyVPifAAqnPXX80uSGvIbQI6f8jQiiapdkZXK45i2nEc195Uznp2+atPe
 ImR0eQN2oaWWxqS7lq1gPYYfblVgLMTESsTi7LS3UxKF/nh8KjZYtqGOrKBYQJKui5PWHMFz
 sH3QH7OOzL86AV+cGRshJzMdsZa9L+96YMd1Hw+KsJr4pmnzZkVns+D0zmEIQh5e/2IateeU
 R/3//2+LBcQJGPtYOh2hnIT0NzR2cBqx3jbqnrUDn2l/InZxDgwWvpI8JEu4OOyR346O2sH3
 Q36ccqvlP/avmCAq2fG1HLuqJkaEAuE4JEeEDz/OHXKGh85jahXj4G4j/fwjBVJOY1aGsJD4
 W89agupn73X23MpTS6cSQxTYHuaW3WCDaqlNIYuQMrshcryK8NhYscWv05KDNFH62JLqt4vP
 xbc02lCEi6OF+Y8l0m8WZCaGETdz78g6zuNnMamnG4eP5D0BZ2cwabMBvKdgMrkMxv6dKHTs
 LMMk6Y68p3a/4JZ8WK3Diy9XCtsRyu5Ko9Yyei3NtlYuB3w
IronPort-HdrOrdr: A9a23:0EDdvKntvTmQDnXfDMMUNmnTnybpDfLd3DAbv31ZSRFFG/Fw8P
 re/8jztCWftN9/Yh0dcK+7Scu9qB/nmqKdwLNhRItKJTOW3FdAdbsSircKoAeMJ8SdzI5gPa
 YJSdkHNDSYNzET5voSizPYLz9P+re6GIXBv5akvg0dMHAXGt5dByQQMHfrLqVMLDM2e6YRJd
 653O5Opz/lWHgeY8ihb0N1OtQr3Oe78q4PU3Y9dm4aAD/nt0La1FbMeyLorCsjbw=3D=3D
X-Talos-CUID: 9a23:GR6id2HDwwSCEtWzqmJk5EcrNp5iL0bb51n8A0qJB0ouTaOsHAo=3D
X-Talos-MUID: 9a23:hOUzSQWZXhCJCcrq/C/ChBpfaN5r2v+3T1BXj84Hg5G9OwUlbg=3D=3D
X-IronPort-Anti-Spam-Filtered: true
X-IronPort-AV: E=3DMcAfee;i=3D"6800,10657,11704"; a=3D"307739782"
X-IronPort-AV: E=3DSophos;i=3D"6.21,297,1763445600";
   d=3D"scan'208";a=3D"307739782"
X-Agari-Original-From: info@medisavehealthcarebd.com
X-Agari-Original-To: lfissering@deloitte.com
X-Agari-Authentication-Results: esa.deloitte.iphmx.com; dkim=3Dnone (messag=
e not signed) header.i=3Dnone;
 spf=3DPass smtp.mailfrom=3Dinfo@medisavehealthcarebd.com
X-Subject-Tagged: True
Received: from usvip2.noc404.com ([192.200.120.82])
  by esa9.deloitte.iphmx.com with ESMTP/TLS/ECDHE-RSA-AES256-GCM-SHA384; 17=
 Feb 2026 21:24:08 -0600
Received: from amontpellier-655-1-320-37.w90-0.abo.wanadoo.fr ([90.0.24.37]=
:45634 helo=3D[172.67.194.152])
        by usvip2.noc404.com with esmtpsa  (TLS1.3) tls TLS_AES_256_GCM_SHA=
384
        (Exim 4.98.1)
        (envelope-from <info@medisavehealthcarebd.com>)
        id 1vsYAc-0000000FsJN-0HaW
        for lfissering@deloitte.com;
        Wed, 18 Feb 2026 03:24:08 +0000
Content-Type: multipart/related; boundary=3D"----=3D_Part_f1cdc4be042d69.ca=
3c684606834b37"
MIME-Version: 1.0
Date: Wed, 18 Feb 2026 05:24:02 +0200
From: AvniSupport <info@medisavehealthcarebd.com>
To: lfissering@deloitte.com
Subject: Current Invoice Notification_#37e8e08c-56d0-f7ca-7e24-726df5acea03
Message-ID: <177138504257.270981.1055917534760383877@medisavehealthcarebd.c=
om>
Content-Transfer-Encoding: quoted-printable
Feedback-ID: campaign-727cd0e1@medisavehealthcarebd.com
X-MSMail-Header: Medisavehealthcarebd
List-Unsubscribe: <mailto:unsubscribe@medisavehealthcarebd.com>, <https://m=
edisavehealthcarebd.com/unsubscribe?email=3Dlfissering%40deloitte.com&t=3Da=
50c69db>
List-Unsubscribe-Post: List-Unsubscribe=3DOne-Click
X-Priority: 1
Importance: High
Priority: urgent
X-AntiAbuse: This header was added to track abuse, please include it with a=
ny abuse report
X-AntiAbuse: Primary Hostname - usvip2.noc404.com
X-AntiAbuse: Original Domain - deloitte.com
X-AntiAbuse: Originator/Caller UID/GID - [47 12] / [47 12]
X-AntiAbuse: Sender Address Domain - medisavehealthcarebd.com
X-Get-Message-Sender-Via: usvip2.noc404.com: authenticated_id: 3@ivory-ivor=
y-684.medisavehealthcarebd.com
X-Authenticated-Sender: usvip2.noc404.com: 3@ivory-ivory-684.medisavehealth=
carebd.com
X-Source:
X-Source-Args:
X-Source-Dir:
Return-Path: info@medisavehealthcarebd.com
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 36da45f1-dd2c-4d1f-af13-5abe46b99921:0
X-MS-Exchange-SkipListedInternetSender: ip=3D[192.200.120.82];domain=3Dusvi=
p2.noc404.com
X-MS-Exchange-ExternalOriginalInternetSender: ip=3D[192.200.120.82];domain=
=3Dusvip2.noc404.com
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: DS1PEPF00017090:EE_|AM0PR85MB0274:EE_
X-MS-Office365-Filtering-Correlation-Id: 13b7601a-ab5d-415f-4876-08de6e9d2f=
7a


--68fda064-7efe-4ad3-8bbd-a06ea6e28640
Content-Type: text/html; charset="us-ascii"
Content-Transfer-Encoding: quoted-printable

<html>
<Head></head><body>
<p><b><font color=3D"#000066" size=3D"3" face=3D"Arial">Delivery has failed=
 to these recipients or groups:</font></b></p>
<font color=3D"#000000" size=3D"2" face=3D"Tahoma"><p><a href=3D"mailto:lfi=
ssering@deloitte.com">lfissering@deloitte.com</a><br>
</font>
<font color=3D"#000000" size=3D"3" face=3D"Arial">Your message couldn't be =
delivered to the recipient because you don't have permission to send to it.=
<p>Ask the recipient's email admin to add you to the accept list for the re=
cipient.</p><p>For more information, see <a href=3D"https://go.microsoft.co=
m/fwlink/?LinkId=3D389365">DSN 5.7.129 Errors in Exchange Online and Office=
 365</a>.</p><br>
</font>
<font color=3D"#000000" size=3D"2" face=3D"Tahoma"><br>
</p>
</font>
<br><br><br><br><br><br>
<font color=3D"#808080" size=3D"2" face=3D"Tahoma"><p><b>Diagnostic informa=
tion for administrators:</b></p>
<p>Generating server: AM0PR85MB0274.NAMPRD85.PROD.OUTLOOK.COM<br>
</p>
<p>lfissering@deloitte.com<br>
Remote server  returned '550 5.7.129 RESOLVER.RST.RestrictedToRecipientsPer=
mission; not authorized to send to recipient because the sender isn't on th=
e recipient's list of senders to accept mail from'<br>
</p>
<p>Original message headers:</p>
<pre>Received: from DM8PR85CA0006.NAMPRD85.PROD.OUTLOOK.COM (2603:10b6:5:2d=
8::33)
 by AM0PR85MB0274.NAMPRD85.PROD.OUTLOOK.COM (2603:10a6:20b:20d::8) with
 Microsoft SMTP Server (version=3DTLS1_2,
 cipher=3DTLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9564.22; Wed, 18 =
Feb
 2026 03:24:14 +0000
Received: from DS1PEPF00017090.namprd03.prod.outlook.com
 (2a01:111:f403:f904::b) by DM8PR85CA0006.outlook.office365.com
 (2603:10b6:5:2d8::33) with Microsoft SMTP Server (version=3DTLS1_3,
 cipher=3DTLS_AES_256_GCM_SHA384) id 15.20.9564.22 via Frontend Transport; =
Wed,
 18 Feb 2026 03:24:12 +0000
Authentication-Results: spf=3Dpass (sender IP is 192.200.120.82)
 smtp.mailfrom=3Dmedisavehealthcarebd.com; dkim=3Dnone (message not signed)
 header.d=3Dnone;dmarc=3Dbestguesspass action=3Dnone
 header.from=3Dmedisavehealthcarebd.com;
Received-SPF: Pass (protection.outlook.com: domain of medisavehealthcarebd.=
com
 designates 192.200.120.82 as permitted sender)
 receiver=3Dprotection.outlook.com; client-ip=3D192.200.120.82;
 helo=3Dusvip2.noc404.com; pr=3DC
Received: from esa.deloitte.iphmx.com (68.232.130.230) by
 DS1PEPF00017090.mail.protection.outlook.com (10.167.17.132) with Microsoft
 SMTP Server (version=3DTLS1_2, cipher=3DTLS_ECDHE_RSA_WITH_AES_256_GCM_SHA=
384) id
 15.20.9632.12 via Frontend Transport; Wed, 18 Feb 2026 03:24:11 +0000
X-CSE-ConnectionGUID: kxaWD6/5SnCFDHmYfD/mvQ=3D=3D
X-CSE-MsgGUID: xFhCU4qkQ3q/x2v3iP0QfA=3D=3D
Authentication-Results-Original: esa.deloitte.iphmx.com; dkim=3Dnone (messa=
ge
 not signed) header.i=3Dnone; spf=3DPass
 smtp.mailfrom=3Dinfo@medisavehealthcarebd.com
Received-SPF: Pass (esa.deloitte.iphmx.com: domain of
  info@medisavehealthcarebd.com designates 192.200.120.82 as
  permitted sender) identity=3Dmailfrom;
  client-ip=3D192.200.120.82; receiver=3Desa.deloitte.iphmx.com;
  envelope-from=3D&quot;info@medisavehealthcarebd.com&quot;;
  x-sender=3D&quot;info@medisavehealthcarebd.com&quot;;
  x-conformance=3Dspf_only; x-record-type=3D&quot;v=3Dspf1&quot;;
  x-record-text=3D&quot;v=3Dspf1 ip4:192.200.120.82 +a +mx
  +ip4:52.129.44.82 ~all&quot;
X-Ironport-Dmarc-Check-Result: validskip
IronPort-SDR: 699530d8_DmSTmo+KRBFoit12pKHlskJLddgd5sGbsNxNGrDw4sE4zk9
 zzCb71hO+zlzZh8qVkTiH1CusueHY3jIFIj70uA=3D=3D
X-Deloitte-MX-Route: IncomingMail
X-External-Sender: True
X-SDR-Check: True
X-ThreatScanner-Verdict: Negative
X-IPAS-Result: =3D?us-ascii?q?A0CODgBLMJVp/1J4yMBagQmBUIJBBxMBIUkCgRIHUZFfh=
?=3D
 =3D?us-ascii?q?GygBQ8IDwEBAQEBAQEBAQkuFg0EAQGSKAIlATcGDgECBAEBAQEDAgMBAQEB=
A?=3D
 =3D?us-ascii?q?QEBAQEBAQsBAQEEAQEBAgEBAgQFAYENE4YgLw2CPR6ECQ8XHQgCJwkOTAdk=
B?=3D
 =3D?us-ascii?q?AEhgmGCIFMDBAEMn1kBgSw/AigBQAEMgQuJFXiBIQgLgQGEfNssBhiBNYhJ=
C?=3D
 =3D?us-ascii?q?wGBVIQcAwGBIoNYJxt9gRB6TYYXBBiBJAEBbYMnglAEK4MFgRKIeYlYgWYD=
W?=3D
 =3D?us-ascii?q?SwBPhcTFwsHBT6BKAN7C24yHVxHPhczWBsHBTuFOYF/DgGGTQEBAYETgSJ4=
b?=3D
 =3D?us-ascii?q?oEfWTQDC209BBIhFBsvj0NBgW91DBMQDQ6BFysVPS2BDD6POYJBKJFHD6Fq=
h?=3D
 =3D?us-ascii?q?CY0CYNDiB6WB4QEjROZVC6HbZBrjgmbBzGBRTkmgS4OHXAVgVmBSU8DGQ+N=
d?=3D
 =3D?us-ascii?q?gGEKr0jQTUSKgIHCwEBAwmSHQGBSQEB?=3D
IronPort-PHdr: A9a23:G0zfpBJL1/MBnj3NZdmcuLxiWUAX0o4c3iYr45Yqw4hDbr6kt8y7e
 hCEubM11BSTB9yGt7ptsKn/jePJYSQ4+5GPsXQPItRndiQuroE7uTJlK+O+TXPBEfjxciYhF
 95DXlI2t1uyMExSBdqsLwaK+i764jEdAAjwOhRoLerpBIHSk9631+ev8JHPfglEnjWwbL19I
 RmssQndqsYajZV8JqosyhbErWZDdvhLy29vOV+ckBHw69uq8pV+6SpQofUh98BBUaX+Yas1S
 KFTASolPW4o+sDlrAHPQwSX6HQTS2kbjBVGDRXd4B71Qpn+vC36tvFg2CaBJs35Uao0WTW54
 Kh1ThLjlToKOCQ48GHTjcxwkb5brRe8rBFx34LYfIeYP+d4c6jAf90VWHBBU95NWCNODI2yb
 5UBAfcCM+hXrYfzvVgBoACkBQm1Hu7i0CNEimPo0aA8zu8vERvG3AslH98WrHnUstP1NKYPX
 +Co1KnI1TLDb+lK2Tzg74XIcxYhof+LXb9rdMre11QgFwLejlqKt4zqITOV2foXvGif8+pgV
 f6ghHQ9qw5vuTeg290ghZXOhoIQ013J8zhyz4kpK9OiUkF7fcKkH4VKtyGcL4Z6X80vTW9ot
 Sg01rELpJG1cDUUxZk62hLSZeCLfouU7x/9VeucIip0iG9ldr6jmxq/8lSsx+PgW8So31hHr
 y5In9/RvX4Ozxze8tWLR/9j8ku7xzqDyxzf5vtZLUwqiabXMZ0szqAompcXrUjPBDP6lF/og
 KKZbEkp9Oql5uL6abv8vJCcLZV7igTmP6QuhMO/BeM4PxATX2iA5+S81aXj8VPjTLVMif05j
 qbUvIzVKMgBuqG5BApV3p4i6xa5ETimzMwVkWQDIV5bYh6LkZTlN03ULPzlE/uzn06gnTR1y
 /zeO73uGJTNLnzNkLf7erZ97lZRyAs1zdBR4JJZEbQBL+zuVU/wr9zXFAE5PBK0w+n5Etp90
 p8eWWKTDaCDKqPdr0SH6f81L+aQY48VvS7xK+I56P72kX85hVgdcLGt3ZsZaXC4Be9mLFuDY
 XrthNcBHnwHsRcgQ+zuj12CUCJTZ2qsUK4m+j47D4emAZ/FRo+2mLOBxju0HoVKZmBaDVCBC
 Wrke52LW/gSbyKcIdVvnyQKWra8U4Mhzw+htBH5xbR9NufU5zYYtYzi1Nht+eHfjxcy9TtoA
 MmSz22AQHt4kX8PRz8zxKxwvE99ylaG0aVgm/JWGtJc6e1VXAomM5DQ1/F1C9XoVQLbYtiEU
 E6oTMy+Dz8+Vt4x2McOY0hlFtu4kh3NwjekD6cOl7yTCpw76qLc0Gb1J8Z603vIzLAvgUEpT
 JgHCGu9m6Qq8gHSA5LOwVifjLugbq8G3STA3GKOwWuVtV9VUAN5VbnFVnkFa0Ha69/+4xD/S
 aSzA+EnLhdZ0pzFba5HZtzyhEtLRPrqPMjeaGurlm28Qx2Pw/SRapH3cX4WxiTXBR8JlgkS+
 SOCOwklHSq7omTRQWA2GV/rZELw7eQ4o3S+AFNhxlzSZBMw27DmxxgOmPa8Rvof06hRvS4gr
 ylzTku7xM/cENGapgBsVKBRbdIm6UlK1W/QsxB9NZW6IqpuwFUZdldKuVjz3TV6A4lNi50qs
 G8y11g1bqeV3FJafi2V3Z35PqHXIWDo8RqjLaXR3xbD1s2L8LwE8vUypgLuuQioEh8m/XR8y
 NRP0n2Tq8mSAAcWVpPtTktx/B9/6a2Pa3Rl7N2F2Xc/Da7htjHDwMkkHuojxT6sctNYMb+YG
 Un5FMhJKdKpLbkDhV6oVQ8cJOdI6OZgPsWocNOD1aKqJ+9+kTKrhGBb4It0yE+G+2x3Teuej
 MVN+O2RwgbSD2S0t1ymqM2iweisBBkfBWP5xSXgA49NeqA0fJ4LDHfoKMqylZ1yhJ/oDnhf8
 lPrR1YLw9SgdhfaaVvhlRZR2kIarT3vmSaxwzFu1TB8qK2Z0X+G2PzsISIOIXUDX2x+lRHpK
 ImwgcodWR2paQYuvB6o6UfhzrZWpKl2K3XTSk5SciL6aWplV8Ncr5K6atVUoNMlqiwRXOm4Z
 lGGVrO7ogMa1jOlFGxblng3cDSju5OxmBIf6irVLXB9q1LcdM1x3h7B6dzRTPpN3jEPXiRyh
 X/cAV30M9Sy/NqSnovOqajnBjjnDMULN3CxlcXQ7mOy/ggISVWnkuq2m8H7HARyyiL929RwF
 G3JoBv6foj3xvG/OONjcFNvAQyZiYIyEYV/n40swZAIjCFL3NPPpSJByD2rd4UBiurkYXEAR
 CAG2YvY+wGj1EBnKXOV24+/V22dx9snbN6/MQZ0kmow6d5HDKCM4flKhyxw9xC5qwzWSf1wk
 jYGwOUj6HMTh/0JswM3wy+RRLsVGAMLWE6k3wTN9N24oKhNMSyud7a3/E9zkdG6Ba+PogxVX
 Gr5cZ44ECV8qM54NRiftR+7opGhc97WY9UJsxSSmBqVlPBbH5U3kutZzToiI2/2umcpjvIql
 RE7l4/vp5CJci8+mcDxSg4dLDD+YNkfvy3gnboL1NjDxJihR91gAmlZBcqyC6jwSHRL76yhZ
 1zGUzR06XKLfNiXVUye8Bs08iiJSsr6cS3LYilDhcNrQB3XTKSwqAUZUDQhl4A0Fg2jwNDhe
 05j6zodoFX/r0kVot8=3D
IronPort-Data: A9a23:quuHKq2KOSryp7QHSPbD5SF7kn2cJEfYwER7XKvMYLTBsI5bp2RUn
 zQcCjzUPP6CYGOmc950bYSxo0IPvZ6DnYViQQNtqSg9HnlHgPSeCIXCJC8cHc8zwu4v7q5Dx
 59DAjUVBJlsFhcwgD/zYuC5xZVb/fjRGeKgYAL8EnkvA1ciE2F51U4Ld9cR2uZAmcK+Dx6Gp
 eT8qsjePE7N8zNvOycf5rnrRClH5ZwegxtG+AZnDRx3lAWGzSdNVstAffvZw0bQG+G4IMbrH
 44v85nkpgs1zz91Yvu5n7DydFE9Q7K6FWCmlnpMVqG+tQNJryo037xTHKJ0hZB/0mjhc3hZk
 b2hhLToIesbFvSkdNc1CXG0JxpD0Zhuo9crF5QeXfu7lCUqe1O0qxln4dpf0Ycwoo6bCkkWn
 RAUxaxkgh2r34qLLLyHpuZEhdQqE+W1e94kvFpO4RHcPPgKBpXdevCfjTNY9G9YasFmAO3AZ
 tJDLzxoZ0iYP1tEPVJ/5JAWxbbywCOnK3sB8grT9fBfD2v7lGSd1JDsNtTSUtmHScROl1iVp
 m/P+3j5CRgAOdaTjzGC9xpAg8eUxXykA9NNROfQGvhCkHOT7VFPER4vDkL8saOn0U+GA+tRA
 hlBksYphfNvrRX1F4OVsweDiHqKvwUHVsBRFeIS5AyJzavI/wvfDW8BJgOtc/Q7r9E3XWZs0
 FiCw4u1QzdotdV5VE5x6J+XvTqNFXZScFQETgEobQ407fWkpZ8K20enoslYLEKjsjHi9djNL
 92isTMghq1Jy8gM3PnjoRbMhDfESnn1ouwdu1i/soGNt1IRiGuZi2qAswizARFod9/xc7V5l
 CJY8/VyFchXZXxN/QTUKAn3IF1W2xp1GGaB2AcxRsNJG8WF9Hm5fIRU6SpzPllkKN1MeDniJ
 ifuhO6QjbcNVEaXgVhfONPgUJR0kPK/T7wIlJn8N7JzX3S4TyfflAkGWKJa9zqFfJEEyP9gZ
 cWoYoy3AGwECK9q6jOzSq1PmfUo3y0yjyebD5zy0x3tg/LUaW+3WIU1FgKETtk4y6eY/yTT0
 dJUbPWRxztlDebRXyjw8KwoF24sE0QVP57NhvZsRraxGTY+QGAFIN3N8IwlYL1gzvh0lP+X3
 3STWX146VvYhF/fIwC4dElMMbfdcpJtnEIJOSUDA1ai+0IkUNyB/ZUgVZgTeJ85/tdC1t9xd
 eEOIO+bM8RMSxPG2R4RaMTlkddcax+E1BOCFAj0RBMdbpJfVwjy1du8RTTW9Q4KEiaTnukvk
 Y2Kjw/0b8IKeFV/MZzwdvmq8WKUgVEcv+BDB23zPdhZfRTXwrhAciDeoKc+HJARFE/l2DCf6
 gexBCUYr8nrp6se0oHApYKAnreTP9pOJGhoNEiF0u/uLgjfxHSp/qFYWuXRfTz9anL9yJ//W
 cprlcPDIN81t3cUlbFjEoRb77M0vPrugL548j5KPlv2a3aTN7cxBUXegOdusPVWy657qDmGf
 BuF2uNnNIWjPOLnF18sJzQZUNmT6MFMihvvtM4LHEHc2hZ23aGmVBxSNiaciSYGI7pSNpgk8
 Ngbu8UXylKejxpyPvasnAdVp3qGEUIDWpUBtp0fPojZtSQwxn5CY63sKCvH5aiSWo8dLm1xH
 CKf35TDjO5610P9UX4LBFnW/O9nnZ9Vkgt7/FwDAFWom9T+mf482iNKwwk3Vgh4yhZm0fp5C
 lN0NkZwG7qCzw1oiOdHQWqoPQNLXz+dxWDc1HoLkzf/Y3Szd2mQMlA4B/mBzHoZ/01YYDJf2
 rOSk0ThcDTyefDOzjkAYlFkp9PjXO5O2FX7wu7/JPu8Hr4+fTbBqY2tbzBRqxLYXOUAtHeer
 uxupOtNean3MBALmJICCq6Y6K8xTS6VL2kTUNBj+6I0RVvnQg+Q4gTXCU6NeZJqHcfooGuYE
 M1lI/xdWyuujBiuqi8pPo9SArtWssNw2v88VOLFGWo0vYGbjAJVi7PL1y2nhGYUU9Rkysk8D
 YXKdgO9KG+bhFoKumrJsftBa0OyXucHbT3a3OywzuI7KLwYvM5sc3AC8L+FukyIAVE24zOVo
 wLxSKvExMNyyYlXvtXNE4cSIy6WON/MROCz3wTriOt3bPTLLcvqnCEEmGnNZgh5E+MYZIVqq
 O6rrtXy4nLggJ83dGLow7+6CKhD4JSJbtp9a87YAiFTonqfZZXK/RAGxmGfLK5JmvN74u2MZ
 VOxSOm0RO4vd+Zt/l9nQAkALE9FEIXyVLnqmg2lpffVChQ97x3OHOn6yVDXN1NkZg06ELygL
 DTrusSexMFS96VNIx4mO8tIIbFFJH3bZK93UOGp6Be5CDGzj0Kgq4nSs0MqyQv2B0muFOf45
 pP4RSbCSimihZGQzP9lntxzmjY1EEdChfIBexNB2txu1BG/Im00DcUcFpQkU5oPoDT5+LDlb
 jScbk0OIH3ZWBJaey7d+/XmZB+UXcYVC+f6Jxso3kKaUDi3D4W+G4lc9j9sznN1Wzn7xtGcN
 tAV/0PvMiiLwp1GQfgZ4tq5i7xFwsz2620p+0enteDPGDcbXKs30UJ+EDp3VSDoF9/HkGPJL
 zMXQUFGWESKdl7jI/1/enJ6GAArgx239m8GNRyw+df4v5mX6MZiy/elYuH67eAlXfQwfbULQ
 Sv6enuJ72WowUcsgKoOue8yoKpKGPmOT9mbLqjieFUopJuOyF8bZuEMoSlea/sZ2l97M0jcn
 TyS8XQBFBy7CERO6oa3lyQN2bxMC0wpMR+YqTXBgwL4rEEF8eX4ejyB7h7KFpXrmq2y42RaW
 GgzaWiSkX23tRzlhyVPifAAqnPXX80uSGvIbQI6f8jQiiapdkZXK45i2nEc195Uznp2+atPe
 ImR0eQN2oaWWxqS7lq1gPYYfblVgLMTESsTi7LS3UxKF/nh8KjZYtqGOrKBYQJKui5PWHMFz
 sH3QH7OOzL86AV+cGRshJzMdsZa9L+96YMd1Hw+KsJr4pmnzZkVns+D0zmEIQh5e/2IateeU
 R/3//2+LBcQJGPtYOh2hnIT0NzR2cBqx3jbqnrUDn2l/InZxDgwWvpI8JEu4OOyR346O2sH3
 Q36ccqvlP/avmCAq2fG1HLuqJkaEAuE4JEeEDz/OHXKGh85jahXj4G4j/fwjBVJOY1aGsJD4
 W89agupn73X23MpTS6cSQxTYHuaW3WCDaqlNIYuQMrshcryK8NhYscWv05KDNFH62JLqt4vP
 xbc02lCEi6OF+Y8l0m8WZCaGETdz78g6zuNnMamnG4eP5D0BZ2cwabMBvKdgMrkMxv6dKHTs
 LMMk6Y68p3a/4JZ8WK3Diy9XCtsRyu5Ko9Yyei3NtlYuB3w
IronPort-HdrOrdr: A9a23:0EDdvKntvTmQDnXfDMMUNmnTnybpDfLd3DAbv31ZSRFFG/Fw8P
 re/8jztCWftN9/Yh0dcK+7Scu9qB/nmqKdwLNhRItKJTOW3FdAdbsSircKoAeMJ8SdzI5gPa
 YJSdkHNDSYNzET5voSizPYLz9P+re6GIXBv5akvg0dMHAXGt5dByQQMHfrLqVMLDM2e6YRJd
 653O5Opz/lWHgeY8ihb0N1OtQr3Oe78q4PU3Y9dm4aAD/nt0La1FbMeyLorCsjbw=3D=3D
X-Talos-CUID: 9a23:GR6id2HDwwSCEtWzqmJk5EcrNp5iL0bb51n8A0qJB0ouTaOsHAo=3D
X-Talos-MUID: 9a23:hOUzSQWZXhCJCcrq/C/ChBpfaN5r2v+3T1BXj84Hg5G9OwUlbg=3D=3D
X-IronPort-Anti-Spam-Filtered: true
X-IronPort-AV: E=3DMcAfee;i=3D&quot;6800,10657,11704&quot;; a=3D&quot;30773=
9782&quot;
X-IronPort-AV: E=3DSophos;i=3D&quot;6.21,297,1763445600&quot;;=20
   d=3D&quot;scan'208&quot;;a=3D&quot;307739782&quot;
X-Agari-Original-From: info@medisavehealthcarebd.com
X-Agari-Original-To: lfissering@deloitte.com
X-Agari-Authentication-Results: esa.deloitte.iphmx.com; dkim=3Dnone (messag=
e not signed) header.i=3Dnone;
 spf=3DPass smtp.mailfrom=3Dinfo@medisavehealthcarebd.com
X-Subject-Tagged: True
Received: from usvip2.noc404.com ([192.200.120.82])
  by esa9.deloitte.iphmx.com with ESMTP/TLS/ECDHE-RSA-AES256-GCM-SHA384; 17=
 Feb 2026 21:24:08 -0600
Received: from amontpellier-655-1-320-37.w90-0.abo.wanadoo.fr ([90.0.24.37]=
:45634 helo=3D[172.67.194.152])
	by usvip2.noc404.com with esmtpsa  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.98.1)
	(envelope-from &lt;info@medisavehealthcarebd.com&gt;)
	id 1vsYAc-0000000FsJN-0HaW
	for lfissering@deloitte.com;
	Wed, 18 Feb 2026 03:24:08 +0000
Content-Type: multipart/related; boundary=3D&quot;----=3D_Part_f1cdc4be042d=
69.ca3c684606834b37&quot;
MIME-Version: 1.0
Date: Wed, 18 Feb 2026 05:24:02 +0200
From: AvniSupport &lt;info@medisavehealthcarebd.com&gt;
To: lfissering@deloitte.com
Subject: Current Invoice Notification_#37e8e08c-56d0-f7ca-7e24-726df5acea03
Message-ID: &lt;177138504257.270981.1055917534760383877@medisavehealthcareb=
d.com&gt;
Content-Transfer-Encoding: quoted-printable
Feedback-ID: campaign-727cd0e1@medisavehealthcarebd.com
X-MSMail-Header: Medisavehealthcarebd
List-Unsubscribe: &lt;mailto:unsubscribe@medisavehealthcarebd.com&gt;, &lt;=
https://medisavehealthcarebd.com/unsubscribe?email=3Dlfissering%40deloitte.=
com&amp;t=3Da50c69db&gt;
List-Unsubscribe-Post: List-Unsubscribe=3DOne-Click
X-Priority: 1
Importance: High
Priority: urgent
X-AntiAbuse: This header was added to track abuse, please include it with a=
ny abuse report
X-AntiAbuse: Primary Hostname - usvip2.noc404.com
X-AntiAbuse: Original Domain - deloitte.com
X-AntiAbuse: Originator/Caller UID/GID - [47 12] / [47 12]
X-AntiAbuse: Sender Address Domain - medisavehealthcarebd.com
X-Get-Message-Sender-Via: usvip2.noc404.com: authenticated_id: 3@ivory-ivor=
y-684.medisavehealthcarebd.com
X-Authenticated-Sender: usvip2.noc404.com: 3@ivory-ivory-684.medisavehealth=
carebd.com
X-Source:
X-Source-Args:
X-Source-Dir:
Return-Path: info@medisavehealthcarebd.com
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 36da45f1-dd2c-4d1f-af13-5abe46b99921:0
X-MS-Exchange-SkipListedInternetSender: ip=3D[192.200.120.82];domain=3Dusvi=
p2.noc404.com
X-MS-Exchange-ExternalOriginalInternetSender: ip=3D[192.200.120.82];domain=
=3Dusvip2.noc404.com
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: DS1PEPF00017090:EE_|AM0PR85MB0274:EE_
X-MS-Office365-Filtering-Correlation-Id: 13b7601a-ab5d-415f-4876-08de6e9d2f=
7a
</pre>
</font>
</body>
</html>=

--68fda064-7efe-4ad3-8bbd-a06ea6e28640--

--43b1ee51-0de4-455b-bef9-bb8a1447359a
Content-Type: message/delivery-status

Reporting-MTA: dns;AM0PR85MB0274.NAMPRD85.PROD.OUTLOOK.COM
Received-From-MTA: dns;esa.deloitte.iphmx.com
Arrival-Date: Wed, 18 Feb 2026 03:24:14 +0000

Original-Recipient: rfc822;lfissering@deloitte.com
Final-Recipient: rfc822;lfissering@deloitte.com
Action: failed
Status: 5.7.129
Diagnostic-Code: smtp;550 5.7.129 RESOLVER.RST.RestrictedToRecipientsPermission; not authorized to send to recipient because the sender isn't on the recipient's list of senders to accept mail from


--43b1ee51-0de4-455b-bef9-bb8a1447359a
Content-Type: message/rfc822

Received: from DM8PR85CA0006.NAMPRD85.PROD.OUTLOOK.COM (2603:10b6:5:2d8::33)
 by AM0PR85MB0274.NAMPRD85.PROD.OUTLOOK.COM (2603:10a6:20b:20d::8) with
 Microsoft SMTP Server (version=TLS1_2,
 cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9564.22; Wed, 18 Feb
 2026 03:24:14 +0000
Received: from DS1PEPF00017090.namprd03.prod.outlook.com
 (2a01:111:f403:f904::b) by DM8PR85CA0006.outlook.office365.com
 (2603:10b6:5:2d8::33) with Microsoft SMTP Server (version=TLS1_3,
 cipher=TLS_AES_256_GCM_SHA384) id 15.20.9564.22 via Frontend Transport; Wed,
 18 Feb 2026 03:24:12 +0000
Authentication-Results: spf=pass (sender IP is 192.200.120.82)
 smtp.mailfrom=medisavehealthcarebd.com; dkim=none (message not signed)
 header.d=none;dmarc=bestguesspass action=none
 header.from=medisavehealthcarebd.com;
Received-SPF: Pass (protection.outlook.com: domain of medisavehealthcarebd.com
 designates 192.200.120.82 as permitted sender)
 receiver=protection.outlook.com; client-ip=192.200.120.82;
 helo=usvip2.noc404.com; pr=C
Received: from esa.deloitte.iphmx.com (68.232.130.230) by
 DS1PEPF00017090.mail.protection.outlook.com (10.167.17.132) with Microsoft
 SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id
 15.20.9632.12 via Frontend Transport; Wed, 18 Feb 2026 03:24:11 +0000
X-CSE-ConnectionGUID: kxaWD6/5SnCFDHmYfD/mvQ==
X-CSE-MsgGUID: xFhCU4qkQ3q/x2v3iP0QfA==
Authentication-Results-Original: esa.deloitte.iphmx.com; dkim=none (message
 not signed) header.i=none; spf=Pass
 smtp.mailfrom=info@medisavehealthcarebd.com
Received-SPF: Pass (esa.deloitte.iphmx.com: domain of
  info@medisavehealthcarebd.com designates 192.200.120.82 as
  permitted sender) identity=mailfrom;
  client-ip=192.200.120.82; receiver=esa.deloitte.iphmx.com;
  envelope-from="info@medisavehealthcarebd.com";
  x-sender="info@medisavehealthcarebd.com";
  x-conformance=spf_only; x-record-type="v=spf1";
  x-record-text="v=spf1 ip4:192.200.120.82 +a +mx
  +ip4:52.129.44.82 ~all"
X-Ironport-Dmarc-Check-Result: validskip
IronPort-SDR: 699530d8_DmSTmo+KRBFoit12pKHlskJLddgd5sGbsNxNGrDw4sE4zk9
 zzCb71hO+zlzZh8qVkTiH1CusueHY3jIFIj70uA==
X-Deloitte-MX-Route: IncomingMail
X-External-Sender: True
X-SDR-Check: True
X-ThreatScanner-Verdict: Negative
X-IPAS-Result: =?us-ascii?q?A0CODgBLMJVp/1J4yMBagQmBUIJBBxMBIUkCgRIHUZFfh?=
 =?us-ascii?q?GygBQ8IDwEBAQEBAQEBAQkuFg0EAQGSKAIlATcGDgECBAEBAQEDAgMBAQEBA?=
 =?us-ascii?q?QEBAQEBAQsBAQEEAQEBAgEBAgQFAYENE4YgLw2CPR6ECQ8XHQgCJwkOTAdkB?=
 =?us-ascii?q?AEhgmGCIFMDBAEMn1kBgSw/AigBQAEMgQuJFXiBIQgLgQGEfNssBhiBNYhJC?=
 =?us-ascii?q?wGBVIQcAwGBIoNYJxt9gRB6TYYXBBiBJAEBbYMnglAEK4MFgRKIeYlYgWYDW?=
 =?us-ascii?q?SwBPhcTFwsHBT6BKAN7C24yHVxHPhczWBsHBTuFOYF/DgGGTQEBAYETgSJ4b?=
 =?us-ascii?q?oEfWTQDC209BBIhFBsvj0NBgW91DBMQDQ6BFysVPS2BDD6POYJBKJFHD6Fqh?=
 =?us-ascii?q?CY0CYNDiB6WB4QEjROZVC6HbZBrjgmbBzGBRTkmgS4OHXAVgVmBSU8DGQ+Nd?=
 =?us-ascii?q?gGEKr0jQTUSKgIHCwEBAwmSHQGBSQEB?=
IronPort-PHdr: A9a23:G0zfpBJL1/MBnj3NZdmcuLxiWUAX0o4c3iYr45Yqw4hDbr6kt8y7e
 hCEubM11BSTB9yGt7ptsKn/jePJYSQ4+5GPsXQPItRndiQuroE7uTJlK+O+TXPBEfjxciYhF
 95DXlI2t1uyMExSBdqsLwaK+i764jEdAAjwOhRoLerpBIHSk9631+ev8JHPfglEnjWwbL19I
 RmssQndqsYajZV8JqosyhbErWZDdvhLy29vOV+ckBHw69uq8pV+6SpQofUh98BBUaX+Yas1S
 KFTASolPW4o+sDlrAHPQwSX6HQTS2kbjBVGDRXd4B71Qpn+vC36tvFg2CaBJs35Uao0WTW54
 Kh1ThLjlToKOCQ48GHTjcxwkb5brRe8rBFx34LYfIeYP+d4c6jAf90VWHBBU95NWCNODI2yb
 5UBAfcCM+hXrYfzvVgBoACkBQm1Hu7i0CNEimPo0aA8zu8vERvG3AslH98WrHnUstP1NKYPX
 +Co1KnI1TLDb+lK2Tzg74XIcxYhof+LXb9rdMre11QgFwLejlqKt4zqITOV2foXvGif8+pgV
 f6ghHQ9qw5vuTeg290ghZXOhoIQ013J8zhyz4kpK9OiUkF7fcKkH4VKtyGcL4Z6X80vTW9ot
 Sg01rELpJG1cDUUxZk62hLSZeCLfouU7x/9VeucIip0iG9ldr6jmxq/8lSsx+PgW8So31hHr
 y5In9/RvX4Ozxze8tWLR/9j8ku7xzqDyxzf5vtZLUwqiabXMZ0szqAompcXrUjPBDP6lF/og
 KKZbEkp9Oql5uL6abv8vJCcLZV7igTmP6QuhMO/BeM4PxATX2iA5+S81aXj8VPjTLVMif05j
 qbUvIzVKMgBuqG5BApV3p4i6xa5ETimzMwVkWQDIV5bYh6LkZTlN03ULPzlE/uzn06gnTR1y
 /zeO73uGJTNLnzNkLf7erZ97lZRyAs1zdBR4JJZEbQBL+zuVU/wr9zXFAE5PBK0w+n5Etp90
 p8eWWKTDaCDKqPdr0SH6f81L+aQY48VvS7xK+I56P72kX85hVgdcLGt3ZsZaXC4Be9mLFuDY
 XrthNcBHnwHsRcgQ+zuj12CUCJTZ2qsUK4m+j47D4emAZ/FRo+2mLOBxju0HoVKZmBaDVCBC
 Wrke52LW/gSbyKcIdVvnyQKWra8U4Mhzw+htBH5xbR9NufU5zYYtYzi1Nht+eHfjxcy9TtoA
 MmSz22AQHt4kX8PRz8zxKxwvE99ylaG0aVgm/JWGtJc6e1VXAomM5DQ1/F1C9XoVQLbYtiEU
 E6oTMy+Dz8+Vt4x2McOY0hlFtu4kh3NwjekD6cOl7yTCpw76qLc0Gb1J8Z603vIzLAvgUEpT
 JgHCGu9m6Qq8gHSA5LOwVifjLugbq8G3STA3GKOwWuVtV9VUAN5VbnFVnkFa0Ha69/+4xD/S
 aSzA+EnLhdZ0pzFba5HZtzyhEtLRPrqPMjeaGurlm28Qx2Pw/SRapH3cX4WxiTXBR8JlgkS+
 SOCOwklHSq7omTRQWA2GV/rZELw7eQ4o3S+AFNhxlzSZBMw27DmxxgOmPa8Rvof06hRvS4gr
 ylzTku7xM/cENGapgBsVKBRbdIm6UlK1W/QsxB9NZW6IqpuwFUZdldKuVjz3TV6A4lNi50qs
 G8y11g1bqeV3FJafi2V3Z35PqHXIWDo8RqjLaXR3xbD1s2L8LwE8vUypgLuuQioEh8m/XR8y
 NRP0n2Tq8mSAAcWVpPtTktx/B9/6a2Pa3Rl7N2F2Xc/Da7htjHDwMkkHuojxT6sctNYMb+YG
 Un5FMhJKdKpLbkDhV6oVQ8cJOdI6OZgPsWocNOD1aKqJ+9+kTKrhGBb4It0yE+G+2x3Teuej
 MVN+O2RwgbSD2S0t1ymqM2iweisBBkfBWP5xSXgA49NeqA0fJ4LDHfoKMqylZ1yhJ/oDnhf8
 lPrR1YLw9SgdhfaaVvhlRZR2kIarT3vmSaxwzFu1TB8qK2Z0X+G2PzsISIOIXUDX2x+lRHpK
 ImwgcodWR2paQYuvB6o6UfhzrZWpKl2K3XTSk5SciL6aWplV8Ncr5K6atVUoNMlqiwRXOm4Z
 lGGVrO7ogMa1jOlFGxblng3cDSju5OxmBIf6irVLXB9q1LcdM1x3h7B6dzRTPpN3jEPXiRyh
 X/cAV30M9Sy/NqSnovOqajnBjjnDMULN3CxlcXQ7mOy/ggISVWnkuq2m8H7HARyyiL929RwF
 G3JoBv6foj3xvG/OONjcFNvAQyZiYIyEYV/n40swZAIjCFL3NPPpSJByD2rd4UBiurkYXEAR
 CAG2YvY+wGj1EBnKXOV24+/V22dx9snbN6/MQZ0kmow6d5HDKCM4flKhyxw9xC5qwzWSf1wk
 jYGwOUj6HMTh/0JswM3wy+RRLsVGAMLWE6k3wTN9N24oKhNMSyud7a3/E9zkdG6Ba+PogxVX
 Gr5cZ44ECV8qM54NRiftR+7opGhc97WY9UJsxSSmBqVlPBbH5U3kutZzToiI2/2umcpjvIql
 RE7l4/vp5CJci8+mcDxSg4dLDD+YNkfvy3gnboL1NjDxJihR91gAmlZBcqyC6jwSHRL76yhZ
 1zGUzR06XKLfNiXVUye8Bs08iiJSsr6cS3LYilDhcNrQB3XTKSwqAUZUDQhl4A0Fg2jwNDhe
 05j6zodoFX/r0kVot8=
IronPort-Data: A9a23:quuHKq2KOSryp7QHSPbD5SF7kn2cJEfYwER7XKvMYLTBsI5bp2RUn
 zQcCjzUPP6CYGOmc950bYSxo0IPvZ6DnYViQQNtqSg9HnlHgPSeCIXCJC8cHc8zwu4v7q5Dx
 59DAjUVBJlsFhcwgD/zYuC5xZVb/fjRGeKgYAL8EnkvA1ciE2F51U4Ld9cR2uZAmcK+Dx6Gp
 eT8qsjePE7N8zNvOycf5rnrRClH5ZwegxtG+AZnDRx3lAWGzSdNVstAffvZw0bQG+G4IMbrH
 44v85nkpgs1zz91Yvu5n7DydFE9Q7K6FWCmlnpMVqG+tQNJryo037xTHKJ0hZB/0mjhc3hZk
 b2hhLToIesbFvSkdNc1CXG0JxpD0Zhuo9crF5QeXfu7lCUqe1O0qxln4dpf0Ycwoo6bCkkWn
 RAUxaxkgh2r34qLLLyHpuZEhdQqE+W1e94kvFpO4RHcPPgKBpXdevCfjTNY9G9YasFmAO3AZ
 tJDLzxoZ0iYP1tEPVJ/5JAWxbbywCOnK3sB8grT9fBfD2v7lGSd1JDsNtTSUtmHScROl1iVp
 m/P+3j5CRgAOdaTjzGC9xpAg8eUxXykA9NNROfQGvhCkHOT7VFPER4vDkL8saOn0U+GA+tRA
 hlBksYphfNvrRX1F4OVsweDiHqKvwUHVsBRFeIS5AyJzavI/wvfDW8BJgOtc/Q7r9E3XWZs0
 FiCw4u1QzdotdV5VE5x6J+XvTqNFXZScFQETgEobQ407fWkpZ8K20enoslYLEKjsjHi9djNL
 92isTMghq1Jy8gM3PnjoRbMhDfESnn1ouwdu1i/soGNt1IRiGuZi2qAswizARFod9/xc7V5l
 CJY8/VyFchXZXxN/QTUKAn3IF1W2xp1GGaB2AcxRsNJG8WF9Hm5fIRU6SpzPllkKN1MeDniJ
 ifuhO6QjbcNVEaXgVhfONPgUJR0kPK/T7wIlJn8N7JzX3S4TyfflAkGWKJa9zqFfJEEyP9gZ
 cWoYoy3AGwECK9q6jOzSq1PmfUo3y0yjyebD5zy0x3tg/LUaW+3WIU1FgKETtk4y6eY/yTT0
 dJUbPWRxztlDebRXyjw8KwoF24sE0QVP57NhvZsRraxGTY+QGAFIN3N8IwlYL1gzvh0lP+X3
 3STWX146VvYhF/fIwC4dElMMbfdcpJtnEIJOSUDA1ai+0IkUNyB/ZUgVZgTeJ85/tdC1t9xd
 eEOIO+bM8RMSxPG2R4RaMTlkddcax+E1BOCFAj0RBMdbpJfVwjy1du8RTTW9Q4KEiaTnukvk
 Y2Kjw/0b8IKeFV/MZzwdvmq8WKUgVEcv+BDB23zPdhZfRTXwrhAciDeoKc+HJARFE/l2DCf6
 gexBCUYr8nrp6se0oHApYKAnreTP9pOJGhoNEiF0u/uLgjfxHSp/qFYWuXRfTz9anL9yJ//W
 cprlcPDIN81t3cUlbFjEoRb77M0vPrugL548j5KPlv2a3aTN7cxBUXegOdusPVWy657qDmGf
 BuF2uNnNIWjPOLnF18sJzQZUNmT6MFMihvvtM4LHEHc2hZ23aGmVBxSNiaciSYGI7pSNpgk8
 Ngbu8UXylKejxpyPvasnAdVp3qGEUIDWpUBtp0fPojZtSQwxn5CY63sKCvH5aiSWo8dLm1xH
 CKf35TDjO5610P9UX4LBFnW/O9nnZ9Vkgt7/FwDAFWom9T+mf482iNKwwk3Vgh4yhZm0fp5C
 lN0NkZwG7qCzw1oiOdHQWqoPQNLXz+dxWDc1HoLkzf/Y3Szd2mQMlA4B/mBzHoZ/01YYDJf2
 rOSk0ThcDTyefDOzjkAYlFkp9PjXO5O2FX7wu7/JPu8Hr4+fTbBqY2tbzBRqxLYXOUAtHeer
 uxupOtNean3MBALmJICCq6Y6K8xTS6VL2kTUNBj+6I0RVvnQg+Q4gTXCU6NeZJqHcfooGuYE
 M1lI/xdWyuujBiuqi8pPo9SArtWssNw2v88VOLFGWo0vYGbjAJVi7PL1y2nhGYUU9Rkysk8D
 YXKdgO9KG+bhFoKumrJsftBa0OyXucHbT3a3OywzuI7KLwYvM5sc3AC8L+FukyIAVE24zOVo
 wLxSKvExMNyyYlXvtXNE4cSIy6WON/MROCz3wTriOt3bPTLLcvqnCEEmGnNZgh5E+MYZIVqq
 O6rrtXy4nLggJ83dGLow7+6CKhD4JSJbtp9a87YAiFTonqfZZXK/RAGxmGfLK5JmvN74u2MZ
 VOxSOm0RO4vd+Zt/l9nQAkALE9FEIXyVLnqmg2lpffVChQ97x3OHOn6yVDXN1NkZg06ELygL
 DTrusSexMFS96VNIx4mO8tIIbFFJH3bZK93UOGp6Be5CDGzj0Kgq4nSs0MqyQv2B0muFOf45
 pP4RSbCSimihZGQzP9lntxzmjY1EEdChfIBexNB2txu1BG/Im00DcUcFpQkU5oPoDT5+LDlb
 jScbk0OIH3ZWBJaey7d+/XmZB+UXcYVC+f6Jxso3kKaUDi3D4W+G4lc9j9sznN1Wzn7xtGcN
 tAV/0PvMiiLwp1GQfgZ4tq5i7xFwsz2620p+0enteDPGDcbXKs30UJ+EDp3VSDoF9/HkGPJL
 zMXQUFGWESKdl7jI/1/enJ6GAArgx239m8GNRyw+df4v5mX6MZiy/elYuH67eAlXfQwfbULQ
 Sv6enuJ72WowUcsgKoOue8yoKpKGPmOT9mbLqjieFUopJuOyF8bZuEMoSlea/sZ2l97M0jcn
 TyS8XQBFBy7CERO6oa3lyQN2bxMC0wpMR+YqTXBgwL4rEEF8eX4ejyB7h7KFpXrmq2y42RaW
 GgzaWiSkX23tRzlhyVPifAAqnPXX80uSGvIbQI6f8jQiiapdkZXK45i2nEc195Uznp2+atPe
 ImR0eQN2oaWWxqS7lq1gPYYfblVgLMTESsTi7LS3UxKF/nh8KjZYtqGOrKBYQJKui5PWHMFz
 sH3QH7OOzL86AV+cGRshJzMdsZa9L+96YMd1Hw+KsJr4pmnzZkVns+D0zmEIQh5e/2IateeU
 R/3//2+LBcQJGPtYOh2hnIT0NzR2cBqx3jbqnrUDn2l/InZxDgwWvpI8JEu4OOyR346O2sH3
 Q36ccqvlP/avmCAq2fG1HLuqJkaEAuE4JEeEDz/OHXKGh85jahXj4G4j/fwjBVJOY1aGsJD4
 W89agupn73X23MpTS6cSQxTYHuaW3WCDaqlNIYuQMrshcryK8NhYscWv05KDNFH62JLqt4vP
 xbc02lCEi6OF+Y8l0m8WZCaGETdz78g6zuNnMamnG4eP5D0BZ2cwabMBvKdgMrkMxv6dKHTs
 LMMk6Y68p3a/4JZ8WK3Diy9XCtsRyu5Ko9Yyei3NtlYuB3w
IronPort-HdrOrdr: A9a23:0EDdvKntvTmQDnXfDMMUNmnTnybpDfLd3DAbv31ZSRFFG/Fw8P
 re/8jztCWftN9/Yh0dcK+7Scu9qB/nmqKdwLNhRItKJTOW3FdAdbsSircKoAeMJ8SdzI5gPa
 YJSdkHNDSYNzET5voSizPYLz9P+re6GIXBv5akvg0dMHAXGt5dByQQMHfrLqVMLDM2e6YRJd
 653O5Opz/lWHgeY8ihb0N1OtQr3Oe78q4PU3Y9dm4aAD/nt0La1FbMeyLorCsjbw==
X-Talos-CUID: 9a23:GR6id2HDwwSCEtWzqmJk5EcrNp5iL0bb51n8A0qJB0ouTaOsHAo=
X-Talos-MUID: 9a23:hOUzSQWZXhCJCcrq/C/ChBpfaN5r2v+3T1BXj84Hg5G9OwUlbg==
X-IronPort-Anti-Spam-Filtered: true
X-IronPort-AV: E=McAfee;i="6800,10657,11704"; a="307739782"
X-IronPort-AV: E=Sophos;i="6.21,297,1763445600"; 
   d="scan'208";a="307739782"
X-Agari-Original-From: info@medisavehealthcarebd.com
X-Agari-Original-To: lfissering@deloitte.com
X-Agari-Authentication-Results: esa.deloitte.iphmx.com; dkim=none (message not signed) header.i=none;
 spf=Pass smtp.mailfrom=info@medisavehealthcarebd.com
X-Subject-Tagged: True
Received: from usvip2.noc404.com ([192.200.120.82])
  by esa9.deloitte.iphmx.com with ESMTP/TLS/ECDHE-RSA-AES256-GCM-SHA384; 17 Feb 2026 21:24:08 -0600
Received: from amontpellier-655-1-320-37.w90-0.abo.wanadoo.fr ([90.0.24.37]:45634 helo=[172.67.194.152])
	by usvip2.noc404.com with esmtpsa  (TLS1.3) tls TLS_AES_256_GCM_SHA384
	(Exim 4.98.1)
	(envelope-from <info@medisavehealthcarebd.com>)
	id 1vsYAc-0000000FsJN-0HaW
	for lfissering@deloitte.com;
	Wed, 18 Feb 2026 03:24:08 +0000
Content-Type: multipart/related; boundary="----=_Part_f1cdc4be042d69.ca3c684606834b37"
MIME-Version: 1.0
Date: Wed, 18 Feb 2026 05:24:02 +0200
From: AvniSupport <info@medisavehealthcarebd.com>
To: lfissering@deloitte.com
Subject: Current Invoice Notification_#37e8e08c-56d0-f7ca-7e24-726df5acea03
Message-ID: <177138504257.270981.1055917534760383877@medisavehealthcarebd.com>
Content-Transfer-Encoding: quoted-printable
Feedback-ID: campaign-727cd0e1@medisavehealthcarebd.com
X-MSMail-Header: Medisavehealthcarebd
List-Unsubscribe: <mailto:unsubscribe@medisavehealthcarebd.com>, <https://medisavehealthcarebd.com/unsubscribe?email=lfissering%40deloitte.com&t=a50c69db>
List-Unsubscribe-Post: List-Unsubscribe=One-Click
X-Priority: 1
Importance: High
Priority: urgent
X-AntiAbuse: This header was added to track abuse, please include it with any abuse report
X-AntiAbuse: Primary Hostname - usvip2.noc404.com
X-AntiAbuse: Original Domain - deloitte.com
X-AntiAbuse: Originator/Caller UID/GID - [47 12] / [47 12]
X-AntiAbuse: Sender Address Domain - medisavehealthcarebd.com
X-Get-Message-Sender-Via: usvip2.noc404.com: authenticated_id: 3@ivory-ivory-684.medisavehealthcarebd.com
X-Authenticated-Sender: usvip2.noc404.com: 3@ivory-ivory-684.medisavehealthcarebd.com
X-Source:
X-Source-Args:
X-Source-Dir:
Return-Path: info@medisavehealthcarebd.com
X-EOPAttributedMessage: 0
X-EOPTenantAttributedMessage: 36da45f1-dd2c-4d1f-af13-5abe46b99921:0
X-MS-Exchange-SkipListedInternetSender: ip=[192.200.120.82];domain=usvip2.noc404.com
X-MS-Exchange-ExternalOriginalInternetSender: ip=[192.200.120.82];domain=usvip2.noc404.com
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: DS1PEPF00017090:EE_|AM0PR85MB0274:EE_
X-MS-Office365-Filtering-Correlation-Id: 13b7601a-ab5d-415f-4876-08de6e9d2f7a

------=_Part_f1cdc4be042d69.ca3c684606834b37
Content-Type: text/plain; charset="us-ascii"
MIME-Version: 1.0
Content-Transfer-Encoding: 7bit

This electronic message and all contents contain information from Apexon which may be privileged, confidential, or otherwise protected from disclosure. The information is intended to be for the addressee(s) only. If you are not an addressee, any disclosure, copy, distribution, or use of the contents of this message is strictly prohibited. If you have received this electronic message in error please notify the sender by reply e-mail to and destroy the original message and all copies. Apexon has taken every reasonable precaution to minimise the risk of malicious content in mail, but is not liable for any damage you may sustain as a result of any malicious content in this e-mail. You should carry out your own malicious content checks before opening the e-mail or attachment.
------=_Part_f1cdc4be042d69.ca3c684606834b37--

--43b1ee51-0de4-455b-bef9-bb8a1447359a--